In the study, the researchers tested phenformin as
a chemotherapy agent in genetically - engineered mice lacking LKB1 and which had advanced stage lung tumors.
Not exact matches
«We remain committed to advancing our IDO pathway inhibitor indoximod, which continues to generate exciting data
in combination with anti-PD-1
agents, cancer vaccines, and
chemotherapy in multiple cancer types including melanoma, prostate cancer, acute myeloid leukemia, and pancreatic cancer.»
Persin, a natural toxin found
in avocados, appears so effective at killing breast cancer cells that it is being considered as a
chemotherapy agent.
Treatment of APL requires cycles of multiple therapeutic
agents, including
chemotherapy,
in three distinct phases: induction, consolidation, and maintenance.
A New York patient is now the second U.S. citizen to be infected with bacteria carrying a «superbug» gene, according to findings published earlier this week
in the journal for Antimicrobial
Agents and
Chemotherapy.
A major breakthrough
in the treatment of cancer was the development of multiple chemotherapeutic
agents (known as combination
chemotherapy).
When 2 years ago Hackett discovered a new way of using a lipid to link drugs to the soluble protein albumin, and that the combination showed promise
in improving the bioavailability of the
chemotherapy agent paclitaxel, he and his adviser thought they had an invention that laid the foundation for a company.
«The network recognizes patterns,» says M. Rizwan Sohail, an infectious disease expert at Mayo Clinic and lead author of the study, presented at the Interscience Conference on Antimicrobial
Agents and
Chemotherapy in San Francisco
in September.
In multiple preclinical models, OMP - 54F28 (FZD8 - Fc) has shown its effectiveness in reducing CSC populations, leading to associated anti-tumor activity, either as a single agent or when combined with chemotherap
In multiple preclinical models, OMP - 54F28 (FZD8 - Fc) has shown its effectiveness
in reducing CSC populations, leading to associated anti-tumor activity, either as a single agent or when combined with chemotherap
in reducing CSC populations, leading to associated anti-tumor activity, either as a single
agent or when combined with
chemotherapy.
The findings, announced online
in the journal Antimicrobial
Agents and
Chemotherapy and funded by the National Institutes of Health, provide a needed boost to the field of antibiotic development, which has been limited
in the last four decades and outpaced by the rise of drug - resistant bacterial strains.
Research has previously shown that veliparib is effective
in combination with
chemotherapy, but little data was available to indicate whether veliparib was effective as a single
agent.
Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena
in which cells cease to divide
in response to DNA damaging
agents, including many
chemotherapies.
New research presented at the American Society of Clinical Oncology (ASCO) 53rd Annual Meeting
in Chicago shows that a previously untested combination of a monoclonal antibody - drug conjugate with a common
chemotherapy agent has a high complete - response rate
in children and young adults with relapsed or refractory Hodgkin lymphoma.
The study will be published
in the January 2014 issue of Antimicrobial
Agents and
Chemotherapy.
The research is published
in Antimicrobial
Agents and
Chemotherapy, a journal of the American Society for Microbiology.
Antibiotic resistance is increasing due to the over prescription of antibiotics, said Ashok Chopra, a professor at UTMB and author of the new study
in the Journal of Antimicrobial
Agents and
Chemotherapy.
«Given development times and manufacturing requirements for new products, repurposing of existing drugs is likely the only solution for outbreaks due to emerging viruses,» the investigators noted
in the paper now online
in the journal Antimicrobial
Agents and
Chemotherapy.
In future, Bandyopadhyay says, better understanding how
chemotherapy agents impact specific biological pathways should allow drug trials to focus on patients who are more likely to respond to the drugs being tested and enable clinicians to identify targeted or combination therapies for patients with a genetic predisposition to resistance.
Researchers from NIH's National Institute of Allergy and Infectious Diseases (NIAID) presented the preliminary study results at the Interscience Conference on Antimicrobial
Agents and
Chemotherapy (ICAAC) meeting
in Denver
in September 2013.
They confirmed this by showing that tumor growth was reduced
in mice treated with an antibody drug that targets TIM - 3 and the
chemotherapy agent paclitaxel, as compared to treatment with paclitaxel alone.
The study was posted online and will appear
in print
in the American Society for Microbiology's journal Antimicrobial
Agents and
Chemotherapy in April.
«This paper reveals a metabolic frailty
in cancer cells that is based on their own production of oxidizing
agents that allows us to utilize existing redox active compounds, like vitamin C, to sensitize cancer cells to radiation and
chemotherapy,» says co-author Garry Buettner, who was one of the first to propose that cancer cells might have a vulnerability to redox active compounds over 40 years ago.
The National Institutes of Health - supported discovery will be described
in the June issue of the journal Antimicrobial
Agents and
Chemotherapy.
When used alongside standard
chemotherapy agents daunorubicin and cytarabine
in a treatment - resistant AML model, 99.7 percent of cancer cells were killed.
She presented the research, conducted by scientists from the University of Lisbon
in Portugal, June 20 at a joint meeting of the American Society for Microbiology and the Interscience Conference on Antimicrobial
Agents and
Chemotherapy.
The research was published
in the June 2013 issue of the journal Antimicrobial
Agents and
Chemotherapy.
A similar antibody - drug conjugate approach is used by the breast cancer
agent T - DM1, which attaches
chemotherapy to an antibody that seeks the HER2 protein
in HER2 + breast cancers.
Findings of the study published
in June
in the journal Antimicrobial
Agents and
Chemotherapy, which is published by the American Society of Microbiology.
Chemotherapy delivered via the placement of a central venous line that remains
in place for the duration of treatment can result
in pre-operative thromboembolic events, which can require the administration of anticoagulation
agents.
Researchers used the mice to show that pemetrexed and gemcitabine worked against human group 3 tumors and that the drugs could be used
in combination with existing
chemotherapy agents to boost treatment effectiveness without undue risk.
The research is published this week
in Antimicrobial
Agents and
Chemotherapy, a journal of the American Society for Microbiology.
The research is published July 11,
in Antimicrobial
Agents and
Chemotherapy, a journal of the American Society for Microbiology.
«Importantly, two
chemotherapy agents — methotrexate and cyclophosphamide — could be dosed to completely reverse obesity without detectable toxicity, even
in mice without cancer,» explains Dr. Myers.
At the Interscience Conference on Antimicrobial
Agents and
Chemotherapy in Chicago, Illinois, this weekend, researchers reported preliminary results from tests of a novel treatment
in 15 HIV - infected people designed to free them from the need to take antiretroviral drugs.
Furthermore, the
agent prevented the drop
in the number of neutrophils (i.e., neutropenia) found
in the blood that is typically caused by 5 - fluorouracil, a
chemotherapy agent commonly used
in the treatment of gastrointestinal and other tumors, such as colon, stomach, pancreas and breast cancers.
Nichol's colleagues presented the results on Sunday at the Interscience Conference on Antimicrobial
Agents and
Chemotherapy in Chicago.
It is also used
in some cancers at much higher doses where the side effects are substantial and similar to other
chemotherapy agents.
The vaccine was tested
in a preliminary clinical trial and used with standard
chemotherapy and an immune - boosting
agent.
In the research, Rieger treated the zebrafish with pharmacological
agents that reduce MMP - 13 activity, with the result that skin defects were improved and
chemotherapy - induced nerve damage was reversed.
For a majority of patients diagnosed with aggressive, high - grade tumors with metastases, the five - year survival rate is about 16 percent, though
chemotherapy has been associated with an improvement
in survival, and new targeted
agents are being tested.
The
agent was previously approved
in December 2016 for the treatment of ovarian cancer specifically associated with BRCA mutations,
in women who had received at least two prior
chemotherapy regimens.
Therefore several trials previous published have as an exclusion criterion atelectasis, pleural effusion and tumor mass more than 5 cm of diameter.8 The rest of the criteria remain the same as
in the case of intravenous infusion, renal function, blood values and performance status have to be appropriate according to the NCCN guidelines.38 Moreover; the administered drug has to be safe
in order to be provided as aerosol, several
chemotherapy agents have been reported to be toxic for the lung parenchyma.
The structure of these transporters is essential to the rational design of
agents which control their function.30 - 32
In our current work we investigated the
chemotherapy agent cisplatin since it the most used
chemotherapy drug for a number of cancer types and the application would have an impact on several cancers.
The immunotherapeutic
agent Ipilumumab has been shown to have a markedly positive effect
in the treatment of patients who are resistant to conventional hormone treatments and
chemotherapy.
Once you know the secrets
in this book you may find yourself still able to enjoy life — and even thrive — while going... View Details
Chemotherapy and Biotherapy Guidelines and Recommendations for Practice by Martha Polovich (Author), MiKeala Olsen (Author), Kris Lefebvre (Author) Order your copy of the fourth edition of the best - selling resource used by more than 101,000 healthcare professionals since 2009 and keep up - to - date on the latest chemotherapy, biotherapy, and targ
Chemotherapy and Biotherapy Guidelines and Recommendations for Practice by Martha Polovich (Author), MiKeala Olsen (Author), Kris Lefebvre (Author) Order your copy of the fourth edition of the best - selling resource used by more than 101,000 healthcare professionals since 2009 and keep up - to - date on the latest
chemotherapy, biotherapy, and targ
chemotherapy, biotherapy, and targeted
agents.
The use of two drugs never tried
in combination before
in ovarian cancer resulted
in a 70 percent destruction of cancer cells already resistant to commonly used
chemotherapy agents, say researchers at Mayo Clinic
in Florida.
The adverse prognostic effect of histone modifier gene mutations was further proven
in a
chemotherapy - independent manner, prompting us to explore bio-therapeutic
agents that can overcome chemoresistance
in PTCL - NOS patients.
Study of the effect of valproate on pulmonary cancer cells,
in combination with
chemotherapy agents.
Kvansakul found that the viral protein blocks multiple pro-apoptotic proteins
in host cells, and that
in a mouse model of Burkitt lymphoma it also renders
chemotherapy agents ineffective, making it a potent oncogene.
Researchers note that while PCI - aided delivery of
chemotherapy to the brain has proven effective
in laboratory tests, additional testing prior to human clinical trials is needed to identify other less - toxic blood - brain barrier
agents to be used
in tandem with the photosensitizer
in the PCI process.